Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma

This publication has 15 references indexed in Scilit:

• Prospects and prejudices of human papillomavirus vaccines in India
  Vaccine, 2008
• Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses
  Vaccine, 2008
• Attenuated measles virus as a vaccine vector
  Vaccine, 2007
• Live Attenuated Measles Vaccine as a Potential Multivalent Pediatric Vaccination Vector
  Viral Immunology, 2005
• Molecular diagnosis of human papillomavirus (HPV) infections
  Journal of Clinical Virology, 2005
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
  The Journal of Pathology, 1999
• A recombinant measles virus expressing biologically active human interleukin-12.
  Journal of General Virology, 1999
• The human CD46 molecule is a receptor for measles virus (Edmonston strain)
  Cell, 1993
• Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
  Proceedings of the National Academy of Sciences, 1992